Literature DB >> 34718573

Distinct roles for the Charcot-Marie-Tooth disease-causing endosomal regulators Mtmr5 and Mtmr13 in axon radial sorting and Schwann cell myelination.

Anna E Mammel1,2, Katherine C Delgado1, Andrea L Chin1, Alec F Condon1,3, Jo Q Hill4, Sue A Aicher4, Yingming Wang5, Lev M Fedorov5, Fred L Robinson1,6.   

Abstract

The form of Charcot-Marie-Tooth type 4B (CMT4B) disease caused by mutations in myotubularin-related 5 (MTMR5; also called SET binding factor 1, SBF1) shows a spectrum of axonal and demyelinating nerve phenotypes. This contrasts with the CMT4B subtypes caused by MTMR2 or MTMR13 (SBF2) mutations, which are characterized by myelin outfoldings and classic demyelination. Thus, it is unclear whether MTMR5 plays an analogous or distinct role from that of its homolog, MTMR13, in the peripheral nervous system (PNS). MTMR5 and MTMR13 are pseudophosphatases predicted to regulate endosomal trafficking by activating Rab GTPases and binding to the phosphoinositide 3-phosphatase MTMR2. In the mouse PNS, Mtmr2 was required to maintain wild-type levels of Mtmr5 and Mtmr13, suggesting that these factors function in discrete protein complexes. Genetic elimination of both Mtmr5 and Mtmr13 in mice led to perinatal lethality, indicating that the two proteins have partially redundant functions during embryogenesis. Loss of Mtmr5 in mice did not cause CMT4B-like myelin outfoldings. However, adult Mtmr5-/- mouse nerves contained fewer myelinated axons than control nerves, likely as a result of axon radial sorting defects. Consistently, Mtmr5 levels were highest during axon radial sorting and fell sharply after postnatal day seven. Our findings suggest that Mtmr5 and Mtmr13 ensure proper axon radial sorting and Schwann cell myelination, respectively, perhaps through their direct interactions with Mtmr2. This study enhances our understanding of the non-redundant roles of the endosomal regulators MTMR5 and MTMR13 during normal peripheral nerve development and disease.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34718573      PMCID: PMC9190308          DOI: 10.1093/hmg/ddab311

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   5.121


  63 in total

Review 1.  The Nodes of Ranvier: Molecular Assembly and Maintenance.

Authors:  Matthew N Rasband; Elior Peles
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-09       Impact factor: 10.005

2.  The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth disease.

Authors:  Fred L Robinson; Jack E Dixon
Journal:  J Biol Chem       Date:  2005-07-05       Impact factor: 5.157

3.  The tumour suppressor LKB1 regulates myelination through mitochondrial metabolism.

Authors:  Shabnam Pooya; Xiaona Liu; V B Sameer Kumar; Jane Anderson; Fumiyasu Imai; Wujuan Zhang; Georgianne Ciraolo; Nancy Ratner; Kenneth D R Setchell; Yutaka Yoshida; Yoshida Yutaka; Michael P Jankowski; Biplab Dasgupta
Journal:  Nat Commun       Date:  2014-09-26       Impact factor: 14.919

4.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

5.  Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.

Authors:  Páris N M Sidiropoulos; Michaela Miehe; Thomas Bock; Elisa Tinelli; Carole I Oertli; Rohini Kuner; Dies Meijer; Bernd Wollscheid; Axel Niemann; Ueli Suter
Journal:  Brain       Date:  2012-03-26       Impact factor: 13.501

6.  Novel SBF1 splice-site null mutation broadens the clinical spectrum of Charcot-Marie-Tooth type 4B3 disease.

Authors:  H Flusser; D Halperin; R Kadir; Z Shorer; I Shelef; O S Birk
Journal:  Clin Genet       Date:  2018-08-09       Impact factor: 4.438

7.  Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2.

Authors:  Kristian Tersar; Matthias Boentert; Philipp Berger; Sonja Bonneick; Carsten Wessig; Klaus V Toyka; Peter Young; Ueli Suter
Journal:  Hum Mol Genet       Date:  2007-09-12       Impact factor: 6.150

Review 8.  Myotubularin phosphoinositide phosphatases in human diseases.

Authors:  Leonela Amoasii; Karim Hnia; Jocelyn Laporte
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

9.  SBF1 mutations associated with autosomal recessive axonal neuropathy with cranial nerve involvement.

Authors:  Andreea Manole; Alejandro Horga; Josep Gamez; Nuria Raguer; Maria Salvado; Beatriz San Millán; Carmen Navarro; Alan Pittmann; Mary M Reilly; Henry Houlden
Journal:  Neurogenetics       Date:  2016-12-22       Impact factor: 2.660

10.  A forward genetic screen in mice identifies Sema3A(K108N), which binds to neuropilin-1 but cannot signal.

Authors:  Janna Merte; Qiang Wang; Craig W Vander Kooi; Sarah Sarsfield; Daniel J Leahy; Alex L Kolodkin; David D Ginty
Journal:  J Neurosci       Date:  2010-04-21       Impact factor: 6.167

View more
  1 in total

1.  A (GCC) repeat in SBF1 reveals a novel biological phenomenon in human and links to late onset neurocognitive disorder.

Authors:  Safoura Khamse; Samira Alizadeh; Stephan H Bernhart; Hossein Afshar; Ahmad Delbari; Mina Ohadi
Journal:  Sci Rep       Date:  2022-09-14       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.